BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3552473)

  • 1. Inducing capacity of the combinations mecillinam-ampicillin and mecillinam-ceftazidime in comparison with the capacity of the compounds administered separately.
    Stobberingh EE; van Boven CP
    Chemotherapy; 1987; 33(2):97-102. PubMed ID: 3552473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime combined with mecillinam: serum bactericidal titres compared with in-vitro synergy against gram-negative bacilli.
    Van der Auwera P; Vandermies A; Lieppe S; Grenier P; Bourguignon AM; Ernst F
    J Antimicrob Chemother; 1988 Jun; 21(6):745-53. PubMed ID: 3045067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.
    Verbist L
    J Antimicrob Chemother; 1985 Dec; 16(6):719-25. PubMed ID: 3879248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory activity of ampicillin and mecillinam on Haemophilus influenzae].
    Dabernat H; Delmas C; Lareng MB
    Pathol Biol (Paris); 1984 May; 32(5):378-80. PubMed ID: 6330648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ampicillin alone and in combination with different concentrations of 6 beta-bromopenicillanic acid, clavulanic acid and mecillinam.
    Stobberingh EE; Houben AW; van Boven CP
    Scand J Infect Dis; 1987; 19(1):105-12. PubMed ID: 3031812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination of cefsulodin and mecillinam.
    Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Jun; 34(6):727-38. PubMed ID: 6268593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mecillinam on Escherichia coli growth curves when given alone and associated with ampicillin.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Scand J Infect Dis; 1986; 18(5):439-45. PubMed ID: 3535050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of mecillinam and mecillinam/ampicillin combinations on Proteus species.
    Hone R; Foley M
    J Antimicrob Chemother; 1980 May; 6(3):410-2. PubMed ID: 6249783
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1632-5. PubMed ID: 3075433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M
    Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
    Stille W; Bischof-Léger E; Helm EB
    Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter.
    Fuglesang JE; Bergan T; Bielecki T; Naterstad A; Namork E
    Infection; 1981; 9(6):290-5. PubMed ID: 6277795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antimicrobial action of mecillinam and ampicillin].
    Khantimer EI
    Antibiotiki; 1983 Aug; 28(8):589-91. PubMed ID: 6314880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
    Neu HC; Chin NX; Labthavikul P
    Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
    Nachamkin I; Gibson G; Sawyer K; Samel C; Skalina D
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):87-96. PubMed ID: 3383549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W; Jarlier V
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiologic study on the prevalence of Enterobacter, Serratia and Pseudomonas strains, producers of cefoxitin-inducible beta-lactamases].
    Marone P; Concia E; Perversi L; Cruciani M
    Boll Ist Sieroter Milan; 1986; 65(5):368-73. PubMed ID: 3103651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model.
    Anderson JD; Eftekhar F; Cleeland R; Kramer MJ; Beskid G
    J Antimicrob Chemother; 1981 Aug; 8(2):121-31. PubMed ID: 6268599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.